The strong association of PNPLA3 with type 4 and NASH-HCC but not with type 1 to type 3 indicates that it is involved in the later stages of NAFLD, particularly in liver fibrosis. The gene discussed is PNPLA3; the disease is metabolic dysfunction-associated steatohepatitis.